Sample,Gene Name,Genotype,Phenotype
N1DL6310,CYP2B6,*1/*1,Normal Metabolizer
N1DL6310,DPYD,Reference/c.1627A>G (*5),Normal Metabolizer
N1DL6310,CYP3A4,*1/*1,Indeterminate
N1DL6310,NUDT15,*1/*1,Normal Metabolizer
N1DL6310,IFNL3,Reference/Reference,Favorable Response
N1DL6310,ABCG2,Reference/rs2231142,Decreased Function
N1DL6310,CYP2C9,*1/*1,Normal Metabolizer
N1DL6310,CYP2C8,*1/*1,Indeterminate
N1DL6310,NAT2,*4/*4,Indeterminate
N1DL6310,VKORC1,Reference/rs9923231,Indeterminate
N1DL6310,G6PD,B/B,Indeterminate
N1DL6310,SLCO1B1,*1/*37,Normal Function
N1DL6310,CACNA1S,Reference/Reference,Uncertain Susceptibility
N1DL6310,CYP2D6,*2/*2,Normal Metabolizer
N1DL6310,CYP2C19,*1/*3,Intermediate Metabolizer
N1DL6310,UGT1A1,*1/*80,Indeterminate
N1DL6310,F5,Reference/Reference,Favorable Response
N1DL6310,RYR1,Reference/Reference,Uncertain Susceptibility
N1DL6310,CFTR,Reference/Reference,Indeterminate
N1DL6310,TPMT,*1/*1,Normal Metabolizer
N1DL6310,CYP3A5,*1/*3,Intermediate Metabolizer
N1DL6310,CYP4F2,*1/*1,Indeterminate
